We use cookies in order to provide better services, give you the best experience of the website and make some analysis. For more information you can read our Cookie Policy and Privacy Policy.
Swiss Medica Science:
Unique Research Facility
The Swiss Medica Science research center brings together experts from diverse fields including bioengineering, natural sciences, and medical sciences to collaborate on innovative approaches to regenerative medicine, stem cell research, and cellular therapy.
The center's research areas include developing bioengineering tools such as 3-D scaffolds and bioreactors that mimic physiological cell microenvironments for stem cells and tissue engineering.

They are also generating induced pluripotent stem cells (iPSCs) from patients with genetically-based disorders and using them to study genetic variants associated with complex traits and human phenotypic variation.
These are the most of the ways stem cells are being used:
For endogenous, or self repair

In drug discovery
Scientists can use stem cells, or tissues grown from them, to search for new drugs that improve their function or alter the progress of disease, as well as to test how drugs might affect different organs (for example, the liver or the kidneys), or how they might affect different people.
Scientists are also exploring ways to stimulate self-repair, coaxing stem cells in the human body to generate healthy cells to heal damaged tissue from within or to prevent further damage.
Scientists are investigating how stem cells form tissues and organs, how aging impacts their function and their role in various diseases and conditions. A better understanding of the inner working of living organisms leads to earlier detection, better diagnosis and more effective treatments for diseases and injury.
To study human development

Offering a wide range of expertise and visionary leadership to advance cell therapy development.
Our research company is a leader in stem cell research, development, and therapy. Our multidisciplinary team of experts bring together extensive knowledge in biomarker and immunogenicity assays, cell therapy operations, bioanalytical analysis, and immune monitoring approaches.
  • High-end expertise in biomarker and immunogenicity assay
    Our lab has cutting-edge knowledge in biomarker and immunogenicity assays, offering full-service biomarker assay development, validation, and implementation to support all stages of your cell therapy project.
  • Qualified global sample management

    Our research fcility specializes in providing services for global studies and offers comprehensive sample management solutions, including kitting, transport, and storage. .
  • Advancing Stem cell therapies

    To stay abreast of the ever-evolving cell therapy field, we established the Precision Adoptive Cell Therapy Working Group, an internal team committed to advising, training, and updating Precision on industry developments.
  • Experienced professionals
    Our cell therapy teams consist of experienced professionals with specialized expertise in clinical trial operations, pharmacovigilance, and medical monitoring, ensuring that each project is guided and supported by experts.

Services that support the development of cell & gene therapies

  • -1-
    Clinical Development Strategy
    We develop customized strategies that take into account the scientific, regulatory, and commercial factors that influence each trial, minimizing risk and accelerating the development process.
  • -2-
    Immune Monitoring
    We employ advanced immune monitoring techniques, such as flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to analyze the immune cells in your samples and assess their effects on patient biology.
  • -3-
    Bioanalytical Testing
    Our laboratory is a globally-renowned leader in immunogenicity testing and offers bioanalytical analysis for biologics, cell therapies, gene therapies, and companion diagnostics development.
Our Research Groups
Our research center is dedicated to exploring the potential of stem cells in developing novel therapies for a variety of diseases and conditions..
  • Cardiovascular Stem Cell Research Group
    The unique properties of stem cells are utilized to create cardiac disease treatments that are both safe and long-lasting.
  • Hematopoietic and Cancer Stem Cell Research Group
    The Hematopoietic Stem Cell Research Group investigates the applications and biology of hematopoietic stem cells, such as bone marrow transplantation, while also exploring new drugs and immunotherapies to more effectively target and eliminate cancer stem cells.
  • Neural Stem Cell Research Group
    The Group combines expertise in various fields of neurobiology to investigate the use of stem cells in developing therapies for neurological conditions, such as spinal cord injury, neurodegeneration, traumatic brain injury, epilepsy, addiction, and schizophrenia. Additionally, the group conducts research on stem cell reprogramming.
Revolutionizing Healthcare with Stem Cell Technology: Mr. Cornelius G. Vink Invests in Swiss Medica Science

The healthcare industry is continuously changing, and developments in medical technology may completely alter how we approach treatment and care. As we explore the developments in stem cells and AI in medicine, we will discuss why Mr. Vink's investment in Swiss Medica Science is positioned to revolutionize healthcare as we now know it.
Contact us
Fill the form to make an inquiry